Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme

Acta Oncologica

Volumn 54, Issue 2, 2015, Pages 200-209

  Haldorsen, Tor ^a   Skare, Gry Baadstrand ^a   Ursin, Giske ^a,b,c   Bjørge, Tone ^a,d  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CANCER SCREENING; CANCER STAGING; COLPOSCOPY; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; HUMAN PAPILLOMA VIRUS TESTING; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; AGE DISTRIBUTION; CANCER GRADING; CERVICAL INTRAEPITHELIAL NEOPLASIA; COMPARATIVE STUDY; CONFIDENCE INTERVAL; EARLY DIAGNOSIS; INCIDENCE; ISOLATION AND PURIFICATION; MIDDLE AGED; NORWAY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PATIENT REFERRAL; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; UTERINE CERVIX; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR;

ADULT; AGE DISTRIBUTION; AGED; ALGORITHMS; ATYPICAL SQUAMOUS CELLS OF THE CERVIX; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; CONFIDENCE INTERVALS; CONTROLLED BEFORE-AFTER STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM GRADING; NORWAY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REFERRAL AND CONSULTATION; TRIAGE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84921728868     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.932433     Document Type: Article

References (25)

1. Council of the European Union. Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union 2003;L327:34-8.
2. IARC Handbooks of Cancer Prevention Volume 10. Cervix cancer screening. Lyon, France: IARC Press;2005.
3. European Commision. European Guidelines for Quality Assurance in Cervical Cancer Screening, 2nd edition. Luxembourg: Office for Official Publications of the European Communities;2008.
4. Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da SD, et al. European guidelines for quality assurance in cervical cancer screening: Recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008;19:342-54.
5. Saslow D, Solomon D, Lawson H W, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.
6. Ronco G, van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 2009;45:2659-70.
7. Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009;45:2649-58.
8. Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J, et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer 1993;29A(Suppl 4):S1-38.
9. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400.
10. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
11. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:280-93.
12. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012;30(Suppl 5):F88-99.
13. Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: Observational before and after study. Br Med J 2006;332:83-5.
14. Kelly RS, Patnick J, Kitchener HC, Moss SM. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: Results from the Sentinel Sites study. Br J Cancer 2011;105:983-8.
15. Faglig ra˚d givningsgruppe for Masseundersøkelsen mot livmorhalskreft. Kvalitetsmanual. Masseundersøkelsen mot livmorhalskreft. Oslo: Kreftregisteret;2005.
16. Nygard JF, Skare GB, Thoresen SO. The cervical cancer screening programme in Norway, 1992-2000: Changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 2002; 9:86-91.
17. Johansen BK, Bjørge T. Cervical cancer screening in Norway. In: Haldorsen T, editor. Cancer in Norway 2009. Special issue: Cancer screening in Norway. Oslo: Cancer Registry of Norway;2011. p. 118-29.
18. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
19. Nyga˚rd M, Røysland K, Cambell S, Dillner J. Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme. Br Med J Open 2013;4:e003460. doi:10.1136/bmjopen-2013-003460.
20. Cleves MA, Gould WW, Gutierrez RG. An introduction to survival analysis using stata. Revised edition. College Station, Texas: Stata Press; 2004.
21. Stata: Release 11. Statistical Software. [computer program]. College Station, Texas: StataCorp LP; 2009.
22. Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. J Low Genit Tract Dis 2008;12:1-7.
23. Arbyn M, Roelens J, Martin-Hirsch P, Leeson S, Wentzensen N. Use of HC2 to triage women with borderline and mild dyskaryosis in the UK. Br J Cancer 2011;105:877-80.
24. Cuzick J, Thomas CJ, Zhang G, Einstein MH, Stoler M, Trupin S, et al. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. Int J Cancer 2013;132:959-66.
25. Nygard JF, Sauer T, Nygard M, Skare GB, Thoresen SO. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: A seven-year prospective study of the Norwegian populationbased screening programme. J Med Screen 2004;11:70-6.